Bionano Genomics, Inc. (BNGO) Financials

$5.36

north_east
$0.02 (0.38%)
Day's range
$5.14
Day's range
$5.37
$50M$50M$0$0-$50M-$50M-$100M-$100M-$150M-$150M-$200M-$200M-$250M-$250MEarning20172017201820182019201920202020202120212022202220232023-100%-100%-200%-200%-300%-300%-400%-400%-500%-500%-600%-600%-700%-700%Profit Margin
Profit Margin
Revenue
Earnings

BNGO Income statement / Annual

Last year (2023), Bionano Genomics, Inc.'s total revenue was $36.12 M, an increase of 29.90% from the previous year. In 2023, Bionano Genomics, Inc.'s net income was -$232.49 M. See Bionano Genomics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Operating Revenue $36.12 M $27.80 M $17.98 M $8.50 M $10.13 M $12.00 M $9.51 M $6.79 M
Cost of Revenue $26.55 M $21.86 M $14.11 M $5.73 M $6.77 M $8.71 M $6.03 M $3.58 M
Gross Profit $9.57 M $5.95 M $3.87 M $2.77 M $3.36 M $3.29 M $3.47 M $3.21 M
Gross Profit Ratio 0.26 0.21 0.22 0.33 0.33 0.27 0.37 0.47
Research and Development Expenses $54.03 M $49.05 M $22.49 M $10.26 M $9.08 M $9.48 M $12.01 M $11.43 M
General & Administrative Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $14.22 M $14.08 M $12.95 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $94.96 M $88.60 M $58.49 M $31.07 M $20.16 M $14.22 M $14.08 M $12.95 M
Other Expenses $75.82 M -$223,000.00 -$59,000.00 -$2.56 M -$3.94 M -$675,853.00 -$289,010.00 -$203,285.00
Operating Expenses $224.81 M $137.64 M $80.98 M $41.32 M $29.24 M $23.70 M $26.09 M $24.38 M
Cost And Expenses $251.36 M $159.50 M $95.08 M $47.05 M $36.00 M $32.42 M $32.12 M $27.96 M
Interest Income $3.31 M $1.51 M $236,000.00 $2.52 M $2.29 M $0.00 $0.00 $0.00
Interest Expense $5.12 M $298,000.00 $927,000.00 $2.52 M $2.29 M $1.38 M $590,927.00 $470,072.00
Depreciation & Amortization $13.71 M $10.10 M $3.97 M $1.47 M $1.13 M $1.32 M $1.50 M $1.12 M
EBITDA -$213.60 M -$120.32 M -$73.86 M -$37.08 M -$26.38 M -$15.78 M -$21.25 M -$17.25 M
EBITDA Ratio -5.91 -4.69 -4.28 -4.53 -2.55 -1.76 -2.25 -2.98
Operating Income Ratio -5.96 -4.74 -4.29 -4.53 -2.55 -1.7 -2.44 -3.12
Total Other Income/Expenses Net -$17.19 M $986,000.00 -$1.05 M -$2.53 M -$3.92 M $1.93 M -$128,004.00 $2.33 M
Income Before Tax -$232.43 M -$130.71 M -$78.15 M -$41.11 M -$29.82 M -$18.48 M -$23.35 M -$18.84 M
Income Before Tax Ratio -6.44 -4.7 -4.35 -4.83 -2.94 -1.54 -2.46 -2.77
Income Tax Expense $62,000.00 $1.88 M -$5.72 M $29,193.00 $21,048.00 $15,511.00 $18,552.00 $12,924.00
Net Income -$232.49 M -$132.60 M -$72.44 M -$41.14 M -$29.84 M -$18.50 M -$23.37 M -$18.85 M
Net Income Ratio -6.44 -4.77 -4.03 -4.84 -2.95 -1.54 -2.46 -2.77
EPS -6.81 -4.58 -2.62 -3.95 -19.92 -26.14 -86.5 -36.06
EPS Diluted -6.81 -4.58 -2.62 -3.95 -19.92 -26.14 -86.5 -36.06
Weighted Average Shares Out $34.15 M $28.92 M $27.68 M $10.43 M $1.50 M $707,712.00 $270,106.00 $522,744.00
Weighted Average Shares Out Diluted $34.15 M $28.92 M $27.68 M $10.43 M $1.50 M $707,713.00 $270,106.00 $522,744.00
Link